Dr. Carrigan et Kk. Knox, HUMAN HERPESVIRUS-6 (HHV-6) ISOLATION FROM BONE-MARROW - HHV-6-ASSOCIATED BONE-MARROW SUPPRESSION IN BONE-MARROW TRANSPLANT PATIENTS, Blood, 84(10), 1994, pp. 3307-3310
These studies tested the hypothesis that human herpesvirus 6 (HHV-6) c
an cause posttransplant bone marrow (BM) suppression in BM transplant
(BMT) patients. Fifteen adult patients who received T-lymphocyte-deple
ted, allogeneic BM transplants and who developed posttransplant BM sup
pression were studied. Detailed chart reviews were used to divide the
patients into two groups: (1) those with diagnosed BM suppression (DBM
S) and (2) those with idiopathic BM suppression (IBMS). BM aspirates o
btained from the patients at the onset of BM suppression were subjecte
d to an HHV-6 isolation procedure using mitogen-stimulated blood monon
uclear cells. BM specimens obtained from another population of BMT pat
ients solely to document engraftment irrespective of their BM function
were also subjected to the HHV-6 isolation procedure as controls. HHV
-6 was isolated from 6 of 15 BM samples from BMT patients with BM supp
ression. BM samples from patients with IBMS were more likely to be pos
itive for HHV-6 than those from patients with DBMS (P < .01). Also, HH
V-6-positive BM were significantly more likely (P < .05) to come from
patients with suppression of more than one BM lineage than HHV-6-negat
ive BM. Finally, samples of BM from an unselected series of BMT patien
ts studied without regard to their BM function were less likely (P < .
01) to be positive for HHV-6 than patients with IBMS. (C) 1994 by The
American Society of Hematology.